CHINA PHARMA HOLDINGS, INC. Deferred Tax Liabilities, Net
CHINA PHARMA HOLDINGS, INC. (CPHI) had Deferred Tax Liabilities, Net of $791.07 thousand as of 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilities · last filed 2018-05-14
- 2018-03-31: Deferred Tax Liabilities, Net $791.07K.
- 2017-12-31: Deferred Tax Liabilities, Net $738.17K.
- 2017-09-30: Deferred Tax Liabilities, Net $703.04K.
- 2017-06-30: Deferred Tax Liabilities, Net $648.10K.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2018-03-31 | $791.07K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $738.17K 10-Q · filed 2018-05-14 |
| 2017-09-30 | $703.04K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $648.10K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $607.09K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $572.35K 10-Q · filed 2017-11-14 |
| 2015-12-31 | $296.89K 10-K · filed 2017-03-31 |
| 2012-12-31 | $95.96K 10-K · filed 2013-03-14 |
| 2011-12-31 | $128.91K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |